# Risk of Recurrent Urethral Stricture After Treatment With Paclitaxel-Coated Dilatation Balloon (Optilume) Compared With Non-coated Dilatation Balloon

> **NCT06795074** · PHASE4 · RECRUITING · sponsor: **Vastra Gotaland Region** · enrollment: 230 (estimated)

## Conditions studied

- Urethral Stricture

## Interventions

- **COMBINATION_PRODUCT:** Optilume
- **DEVICE:** UroMax Ultra

## Key facts

- **NCT ID:** NCT06795074
- **Lead sponsor:** Vastra Gotaland Region
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-16
- **Primary completion:** 2029-02
- **Final completion:** 2031-02
- **Target enrollment:** 230 (ESTIMATED)
- **Last updated:** 2026-01-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06795074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06795074, "Risk of Recurrent Urethral Stricture After Treatment With Paclitaxel-Coated Dilatation Balloon (Optilume) Compared With Non-coated Dilatation Balloon". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06795074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*